Douglas W.P. Hay

8.2k total citations
134 papers, 5.8k citations indexed

About

Douglas W.P. Hay is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Douglas W.P. Hay has authored 134 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Physiology, 56 papers in Molecular Biology and 41 papers in Cellular and Molecular Neuroscience. Recurrent topics in Douglas W.P. Hay's work include Asthma and respiratory diseases (58 papers), Nitric Oxide and Endothelin Effects (36 papers) and Neuropeptides and Animal Physiology (36 papers). Douglas W.P. Hay is often cited by papers focused on Asthma and respiratory diseases (58 papers), Nitric Oxide and Endothelin Effects (36 papers) and Neuropeptides and Animal Physiology (36 papers). Douglas W.P. Hay collaborates with scholars based in United States, United Kingdom and Australia. Douglas W.P. Hay's co-authors include Mark A. Luttmann, David C. Underwood, Theodore J. Torphy, Bradley J. Undem, Stephen G. Farmer, David Raeburn, Ruth R. Osborn, Jeffrey S. Fedan, Roseanna M. Muccitelli and Roy G. Goldie and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Douglas W.P. Hay

134 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas W.P. Hay United States	44	3.1k	2.2k	1.7k	1.1k	951	134	5.8k
Pierré Sirois Canada	38	2.8k 0.9×	1.5k 0.7×	1.2k 0.7×	547 0.5×	956 1.0×	310	6.2k
Hidde Bult Belgium	45	2.1k 0.7×	1.6k 0.7×	644 0.4×	742 0.7×	1.3k 1.4×	188	6.4k
Raymond B. Penn United States	44	2.2k 0.7×	4.6k 2.1×	1.1k 0.7×	2.1k 1.9×	813 0.9×	117	7.0k
Nelly Frossard France	40	2.0k 0.7×	1.4k 0.6×	965 0.6×	980 0.9×	1.3k 1.3×	170	5.0k
Herman Meurs Netherlands	44	3.1k 1.0×	1.4k 0.7×	2.0k 1.2×	559 0.5×	636 0.7×	135	4.9k
Priscilla J. Piper United Kingdom	37	3.2k 1.0×	1.2k 0.5×	1.5k 0.9×	625 0.5×	733 0.8×	143	6.3k
R.J. Flower United Kingdom	45	1.4k 0.4×	2.7k 1.2×	740 0.4×	645 0.6×	1.4k 1.5×	106	7.9k
Yassine Amrani United States	43	2.5k 0.8×	1.6k 0.7×	1.2k 0.7×	403 0.4×	1.7k 1.8×	108	5.1k
Pierre Pacaud France	48	1.3k 0.4×	3.3k 1.5×	729 0.4×	998 0.9×	292 0.3×	108	6.0k
Takehiko Yokomizo Japan	48	2.4k 0.8×	3.3k 1.5×	646 0.4×	568 0.5×	2.2k 2.3×	186	8.2k

Countries citing papers authored by Douglas W.P. Hay

Since Specialization

Citations

This map shows the geographic impact of Douglas W.P. Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W.P. Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W.P. Hay more than expected).

Fields of papers citing papers by Douglas W.P. Hay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas W.P. Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W.P. Hay. The network helps show where Douglas W.P. Hay may publish in the future.

Co-authorship network of co-authors of Douglas W.P. Hay

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas W.P. Hay. A scholar is included among the top collaborators of Douglas W.P. Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas W.P. Hay. Douglas W.P. Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bäck, Magnus, Charles Brink, Nan Chiang, et al.. (2019). Leukotriene receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019(4). 1 indexed citations

Mehta, Rajendra H., Sean van Diepen, James P. Meza, et al.. (2016). Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial. American Heart Journal. 182. 62–71. 19 indexed citations

Salmon, M, Mark A. Luttmann, James J. Foley, et al.. (2013). Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases. Journal of Pharmacology and Experimental Therapeutics. 345(2). 260–270. 64 indexed citations

Myers, Allen C., Roy G. Goldie, & Douglas W.P. Hay. (2004). A Novel Role for Tachykinin Neurokinin-3 Receptors in Regulation of Human Bronchial Ganglia Neurons. American Journal of Respiratory and Critical Care Medicine. 171(3). 212–216. 28 indexed citations

Brink, Charles, Sven‐Erik Dahlén, Jeffrey M. Drazen, et al.. (2003). International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacological Reviews. 55(1). 195–227. 228 indexed citations

Hay, Douglas W.P., Mark A. Luttmann, & Stephen A. Douglas. (2000). Human urotensin‐II is a potent spasmogen of primate airway smooth muscle. British Journal of Pharmacology. 131(1). 10–12. 26 indexed citations

Hay, Douglas W.P.. (1999). PUTATIVE MEDIATOR ROLE OF ENDOTHELIN‐1 IN ASTHMA AND OTHER LUNG DISEASES. Clinical and Experimental Pharmacology and Physiology. 26(2). 168–171. 33 indexed citations

Medhurst, Andrew D., Douglas W.P. Hay, Andrew A. Parsons, Lenox D. Martin, & Don E. Griswold. (1997). In vitro and in vivo characterization of NK₃ receptors in the rabbit eye by use of selective non‐peptide NK₃ receptor antagonists. British Journal of Pharmacology. 122(3). 469–476. 31 indexed citations

Underwood, David C., Ruth R. Osborn, S J Newsholme, T J Torphy, & Douglas W.P. Hay. (1996). Persistent Airway Eosinophilia After Leukotriene (LT) D4 Administration in the Guinea Pig: Modulation by the LTD4 Receptor Antagonist, Pranlukast, or an Interleukin-5 Monoclonal Antibody. American Journal of Respiratory and Critical Care Medicine. 154(4). 850–857. 118 indexed citations

10.

Hay, Douglas W.P., Peter J. Henry, & R.G. Goldie. (1996). Is Endothelin-1 a Mediator in Asthma?. American Journal of Respiratory and Critical Care Medicine. 154(6). 1594–1597. 35 indexed citations

11.

Goldie, R.G., Peter J. Henry, Patrick G. Knott, et al.. (1995). Endothelin-1 Receptor Density, Distribution, and Function in Human Isolated Asthmatic Airways. American Journal of Respiratory and Critical Care Medicine. 152(5). 1653–1658. 73 indexed citations

12.

Reynolds, Curt J., et al.. (1995). Effects of Intranasal Administration of Endothelin-1 to Allergic and Nonallergic Individuals. American Journal of Respiratory and Critical Care Medicine. 152(6). 1757–1764. 36 indexed citations

13.

Torphy, Theodore J., Mary S. Barnette, Douglas W.P. Hay, & David C. Underwood. (1994). Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.. Environmental Health Perspectives. 102(suppl 10). 79–84. 29 indexed citations

14.

Hay, Douglas W.P., Walter C. Hubbard, & Bradley J. Undem. (1993). Relative contributions of direct and indirect mechanisms mediating endothelin‐induced contraction of guinea‐pig trachea. British Journal of Pharmacology. 110(3). 955–962. 15 indexed citations

15.

Osborn, Ruth R., Douglas W.P. Hay, Martin A. Wasserman, & Theodore J. Torphy. (1992). SK&F 104353, a selective leukotriene receptor antagonist, inhibits leukotriene D4- and antigen-induced bronchoconstriction in cynomolgus monkeys. Pulmonary Pharmacology. 5(3). 153–157. 16 indexed citations

16.

Farmer, Stephen G. & Douglas W.P. Hay. (1991). The airway epithelium : physiology, pathophysiology, and pharmacology. M. Dekker eBooks. 32 indexed citations

17.

Goldie, Roy G., Lynette Fernandes, Stephen G. Farmer, & Douglas W.P. Hay. (1990). Airway epithelium-derived inhibitory factor. Trends in Pharmacological Sciences. 11(2). 67–70. 60 indexed citations

18.

Wadsworth, R. M., et al.. (1990). The effect of inhibitors of prostaglandin formation on contraction of the rat, rabbit and human vas deferens. Journal of Autonomic Pharmacology. 10(1). 55–64. 8 indexed citations

19.

Hay, Douglas W.P., Stephen G. Farmer, David Raeburn, et al.. (1987). Differential effects of epithelium removal on the responsiveness of guinea‐pig tracheal smooth muscle to bronchoconstrictors. British Journal of Pharmacology. 92(2). 381–388. 36 indexed citations

20.

Fedan, Jeffrey S., V A Robinson, Douglas W.P. Hay, & Karin Weber. (1986). An overview of species differences in the effects of a water extract of cotton bract on isolated airway smooth muscle, and effects of E. coli lipopolysaccharide.. Environmental Health Perspectives. 66. 159–165. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact